Internal Medicine, Rheumatology · Roswell, NM
NPI
1457872350
Since 2017
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
400 Military Heights Pl
Roswell, NM, 88201
Phone (575) 627-9500
Groups this clinician bills Medicare through
Medicare paid, 2024
$848K
66,128 services
Medicare patients, 2024
326
Average age 71
Drug cost, 2024
$3.8M
1,802 prescriptions
Company payments, 2025
$267
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad Ramahi was code J3262 (injection, tocilizumab, 1 mg), 36,762 times for 11 patients. In total Ahmad Ramahi billed 66,128 services in 138 codes, and Medicare paid $848K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 36,762 | 11 | $4.10 | $151K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 6,925 | 13 | $33.92 | $235K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,617 | 49 | $0.10 | $556 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,070 | 13 | $24.99 | $52K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,916 | 46 | $0.23 | $433 |
| 99214 Office E&M - Established | Office | 1,035 | 297 | $83.36 | $86K |
| 36415 Venipuncture Blood Collection | Office | 541 | 206 | $8.63 | $4,669 |
| 96375 Injection Administration | Office | 468 | 52 | $10.75 | $5,031 |
| 85025 Blood Count | Office | 443 | 190 | $7.58 | $3,356 |
| 80053 Clinical Chemistry | Office | 419 | 187 | $10.33 | $4,327 |
| 96413 Chemotherapy Administration | Office | 276 | 50 | $87.57 | $24K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 274 | 48 | $0.64 | $176 |
| 86140 Clinical Chemistry | Office | 190 | 135 | $5.04 | $958 |
| 85652 Clinical Chemistry | Office | 181 | 130 | $2.65 | $480 |
| 82784 Immunoassay | Office | 155 | 37 | $9.03 | $1,399 |
By year: 2022 $264K for 18,587 services; 2023 $737K for 43,302 services; 2024 $848K for 66,128 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 541 | 206 | $8.63 | $4,669 |
| 85025 Blood Count | 443 | 190 | $7.58 | $3,356 |
| 80053 Clinical Chemistry | 419 | 187 | $10.33 | $4,327 |
| 86140 Clinical Chemistry | 190 | 135 | $5.04 | $958 |
| 85652 Clinical Chemistry | 181 | 130 | $2.65 | $480 |
| 82784 Immunoassay | 155 | 37 | $9.03 | $1,399 |
| 80076 Clinical Chemistry | 42 | 37 | $7.82 | $328 |
| 86431 Immunoassay | 33 | 33 | $5.56 | $183 |
| 82565 Clinical Chemistry | 33 | 29 | $4.87 | $161 |
| 84550 Clinical Chemistry | 31 | 28 | $4.43 | $137 |
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad Ramahi prescribed most often to Medicare patients was Prednisone, with 315 prescriptions and refills. In total Ahmad Ramahi wrote 1,802 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 315 | 504 | 104 | $2,366 |
| Methotrexate Methotrexate Sodium | 301 | 570 | 72 | $5,786 |
| Hydroxychloroquine Sulfate Generic | 225 | 398 | 51 | $5,635 |
| Leflunomide Generic | 163 | 281 | 42 | $6,799 |
| Humira Pen Adalimumab | 151 | 164 | 18 | $1.2M |
| Orencia Clickject Abatacept | 58 | 58 | Under 11 | $335K |
| Enbrel Sureclick Etanercept | 45 | 45 | Under 11 | $332K |
| Mycophenolate Mofetil Generic | 43 | 53 | Under 11 | $5,984 |
| Orencia Abatacept | 40 | 40 | Under 11 | $239K |
| Kevzara Sarilumab | 36 | 38 | Under 11 | $163K |
| Actemra Actpen Tocilizumab | 33 | 40 | Under 11 | $146K |
| Folic Acid Generic | 31 | 59 | Under 11 | $195 |
| Methylprednisolone Generic | 28 | 51 | Under 11 | $560 |
| Sulfasalazine Generic | 27 | 49 | Under 11 | $891 |
| Leucovorin Calcium Generic | 25 | 69 | Under 11 | $238 |
Brand drugs: - claims; generic drugs: 1,215 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmad Ramahi $267 ($267 in general payments such as food, travel and fees) from 8 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $53.76.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $53.76 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $53.19 |
| Abbvie Inc. ABBV | 2 | $39.4 |
| Inspire Medical Systems, Inc. INSP | 1 | $34.63 |
| Daiichi Sankyo Inc. 4568.T | 1 | $23.47 |
| Sobi, Inc SOBI.ST | 1 | $23.07 |
| Gilead Sciences, Inc. GILD | 1 | $20.94 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $18.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.